Quidelortho Corp at Morgan Stanley Global Healthcare Conference Transcript
All right. Thanks, everyone, for joining us. My name is Tejas Savant, and I'm the Life Science Tools And Diagnostics Analyst at Morgan Stanley. It's my pleasure to host Quidel this afternoon. And from the company, we have Doug Bryant, CEO; and Joe Busky, CFO. Thanks for doing this.
Before we get started, a quick disclaimer here for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.
Questions & Answers
So with that, Doug, we'll get started. '22 has been quite a transformational year for the Quidel story. Beyond the close of the Ortho transaction, can you highlight some of your key accomplishments year-to-date and just give us a high-level overview of what you're most excited about as we look to '23?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |